When examining only patients with malignant PEComa, there was a similar trend toward worse DCR for those with a primary uterine site, both when considering all treatments and only mTOR inhibitors, but statistical significance was not reached (Supplementary Table S5). This evidence concerns the gene MTOR and neoplasm with perivascular epithelioid cell differentiation.